Vivimed Labs has launched Favulous, its generic version of Covid-19 drug Favipiravir Tablet 200 mg and 400 mg in India. The launch follows the approval secured by the Hyderabad-based specialty chemicals and pharma company secured approval from the Indian Director General of Health Services (DGHS) for manufacturing and marketing Favipiravir. Vivimed Labs said that it […]
Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm’s antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in patients with mild to moderate symptoms. The Indian pharma company has been granted manufacturing and marketing approval from the Drug Controller General of India (DCGI), a department of the Central […]